Target intelligence / Profile preview

Voltage-dependent calcium channel α2δ-1 subunit (α2δ-1)

Target
α2δ-1
Molecular classification
Ion channel auxiliary subunit, Auxiliary subunit of voltage-gated calcium channel, Voltage-gated calcium channel subunit
01

Overview

The **voltage-dependent calcium channel α2δ-1 subunit** is an **auxiliary protein** associated with high-voltage–activated (e.g., L-type and N-type) calcium channels in neurons, muscle, and cardiac tissue[1][2][5][7]. It is anchored to the extracellular side of the membrane, increasing calcium current density by promoting trafficking and functional expression of the α1 pore-forming subunits on the plasma membrane and altering channel gating properties[1][3][5]. The α2δ-1 subunit also acts as a receptor for gabapentinoid drugs (gabapentin, pregabalin), which alleviates neuropathic pain by inhibiting pathological channel trafficking and neurotransmitter release[4][7]. Beyond its auxiliary channel functions, α2δ-1 is involved in synaptic organization through interactions with thrombospondins and is implicated in multiple neurological and cardiovascular disorders[6][7].

Other names
Calcium channel, voltage-dependent, α2/δ subunit 1CACNA2D1α2δ1Calcium channel α2/δ-1 subunit
02

Mechanism of action

Gabapentinoids bind to the α2δ-1 subunit, inhibiting trafficking of voltage-gated calcium channels to the membrane, reducing synaptic calcium influx and neurotransmitter release, thus diminishing pain signaling

03

Biological functions

Regulation of calcium channel trafficking to the plasma membraneModulation of calcium current density and channel activation/inactivation kineticsSynaptic development and plasticityMediating synaptogenic effects of thrombospondinsRegulation of presynaptic neurotransmitter release
04

Disease associations

Neuropathic painEpilepsyCardiovascular disease (cardiac arrhythmia)Other neuropsychiatric and neurodevelopmental disorders
05

Safety considerations

Sedation and dizziness from α2δ-1-binding drugsPotential for abuse/misuse of gabapentinoidsTherapeutic selectivity: expression in heart and CNS may lead to off-target effects (e.g., cardiac or CNS adverse events)
06

Interacting drugs

Gabapentin

2 more in the full profile.

07

Biomarkers

Increased α2δ-1 expression is a biomarker for neuropathic pain states and may help predict response to gabapentinoids in neuropathic pain

Beyond the preview

Go deeper on Voltage-dependent calcium channel α2δ-1 subunit (α2δ-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent calcium channel α2δ-1 subunit (α2δ-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call